Sonoma Pharmaceuticals (NASDAQ: SNOA) reported Q4 EPS of ($0.33). Revenue for the quarter came in at $5.56 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals (SNOA) click here.